CVL237 tablets

CVL237 · Convalife (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CVL237 tablets, covering 2024-03-05 to 2024-03-05. Get the full timeline:

Most recent: Clinical Trial Update: CVL237 Tablets for APDS/PASLI [Phase 2, Phase 3]